CLAT 2026 Sample Paper PDF: With just one day left for the CLAT UG 2026 exam, scheduled on December 07, 2025, candidates must maximise their revision with targeted and structured practice. Solving the ...

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...

The amount of noise The Row’s annual sample sale generated last weekend was perhaps antithetical to the brand’s ultimate quiet luxury status. But what else could be expected? The brand’s legions of ...

As men get older, it’s common to notice changes when going to the bathroom. If you feel like you can’t fully empty your bladder, you have a weak urine stream, or you’re waking up often at night to use ...

Marc Santos is a Guides Staff Writer from the Philippines. He's a seasoned writer with over four years of industry experience, and he is an enjoyer of all things difficult in gaming. If Marc's not ...

Men with benign prostatic hyperplasia (BPH) appear to have higher risks for chronic kidney disease (CKD) and kidney stones. Men with benign prostatic hyperplasia (BPH) are at increased risk for ...

A trial of a permanent prostatic urethral stent for treatment of BPH demonstrated early success. A novel prostatic urethral stent can reduce lower urinary tract symptoms (LUTS) in men with benign ...

This mosaic is made up of more than 100 images captured by NASA’s Viking 1 orbiter, which operated around Mars from 1976 to 1980. The scar across the center of the planet is the vast Valles Marineris ...

The US Food and Drug Administration has approved crinecerfont (Crenessity) for use in combination with glucocorticoids in the treatment of adults and children aged 4 years or older with classic ...

After seven decades with no advances in the treatment of the genetic disorder classic congenital adrenal hyperplasia (CAH), Neurocrine Biosciences has scored FDA approval for its first-in-class, twice ...

Please provide your email address to receive an email when new articles are posted on . The FDA approved crinecerfont to treat patients with congenital adrenal hyperplasia. The drug directly reduces ...